Market Wizard Anil Singhvi's Top Picks: Buy Concord Biotech
Anil Singhvi shares his top stock picks
Stock MarketAnil SinghviConcord BiotechMedplus HealthItd CementationPrestige Estates ProjectsBrigade EnterprisesCampus ActivewearReal EstateMay 29, 2024
**Buy Concord Biotech shares**
Anil Singhvi suggests buying Concord Biotech shares for targets of Rs 1,425, Rs 1,450, and Rs 1,490 with a stop loss at Rs 1,350, citing strong results.
**Buy MedPlus Health shares**
The market guru suggests buying MedPlus Health shares for targets of Rs 718, Rs 730, and Rs 740 with a stop loss at Rs 690. MedPlus Health Services' quarterly numbers were strong on all fronts, but the stock hasn't performed in the last one year.
**Buy ITD Cementation shares**
Anil Singhvi recommends buying ITD Cementation shares for targets of Rs 410, Rs 415, and Rs 425 with a stop loss at Rs 395. The company has staged its best quarterly performance and has a strong order book.
**Prestige Estates Projects results better than estimates**
The market guru points out that the margin improvement staged by the real estate developer is strong. Prestige Estates Projects' margin improved by 1,230 basis points on a year-on-year basis to 38.2 per cent in the March quarter.
**Brigade Enterprises results extraordinarily strong**
The market wizard notes that Brigade Enterprises' results are extraordinarily strong, but the stock has rallied 23 per cent in three months and 125 per cent in a year.
**Buy Campus Activewear shares**
Anil Singhvi suggests buying Campus Activewear shares for targets of Rs 256 and Rs 260 with a stop loss at Rs 245, citing a strong set of quarterly numbers.
Anil Singhvi is a well-known market wizard with a strong track record of making accurate stock calls. His recommendations are highly sought after by investors and traders.
IRCTC, Concord Biotech, MedPlus Health, ITD Cementation, Prestige Estates Projects, Brigade Enterprises, and Campus Activewear are leading companies in their respective sectors.
Frequently Asked Questions
Who is Anil Singhvi? A: Anil Singhvi is a well-known market wizard with a strong track record of making accurate stock calls Q: What are Anil Singhvi's top stock picks? A: Anil Singhvi's top stock picks include Concord Biotech MedPlus Health ITD Cementation Prestige Estates Projects Brigade Enterprises and Campus Activewear Q: Why should I buy Concord Biotech shares? A: Anil Singhvi suggests buying Concord Biotech shares due to strong results Q: What is the target price for MedPlus Health shares? A: The target price for MedPlus Health shares is Rs 718 Rs 730 and Rs 740 with a stop loss at Rs 690 Q: Why are Brigade Enterprises' results considered strong? A: Brigade Enterprises' results are considered strong due to a 23 per cent rally in three months and a 125 per cent rally in a year
Answer not available
Tags:
Related News Articles
Elderly Man Duped of ₹2.43 Crore in Mumbai Flat Fraud: Developers and Real Estate Agent Booked
A 64-year-old man was allegedly defrauded of ₹2.43 crore by Shree Jee Developers and a real estate agent in Kandivali, Mumbai.
Bengaluru's Exorbitant Security Deposits: A 2BHK Rented Out for ₹43,000 pm with ₹2.5 Lakh Security Deposit
Rents in Koramangala have grown roughly 5% year-on-year, with landlords charging high security deposits. Bengaluru's rental market is facing a crisis with tenants struggling to cope with ever-changing demands from landlords.
Axis Ecorp Expands into Fractional Ownership Market with Luxury Holiday Homes
Axis Ecorp, a prominent player in the real estate sector, has entered the fractional ownership market with a focus on luxury holiday homes.
Germany's Property Market Shows Signs of Recovery, but Caution Prevails
Germany, one of Europe’s hardest-hit countries in the real estate downturn, is beginning to see a slight improvement in its property market, though industry experts caution that a full recovery will be slow.
MahaRERA Orders MHADA to Address Structural Issues in Pune Housing Project
A winner of an MHADA lottery apartment in Haveli, Pune district, has filed a complaint with MahaRERA, highlighting significant structural defects in the housing unit. MahaRERA has now directed MHADA to resolve these issues promptly.
Real Estate Regulatory Authority (RERA) Updates: November 18-24, 2024
Recent decisions by various state RERA authorities highlight the ongoing efforts to protect homebuyers' rights and ensure compliance by developers. This week, notable actions include refunds, penalties, and settlements in Haryana, Telangana, West Bengal,